UNIGE document Scientific Article
previous document  unige:77978  next document
add to browser collection
Title

Therapeutic drug monitoring of the β-lactam antibiotics: what is the evidence and which patients should we be using it for?

Authors
Huttner, Angela
Hope, William W
Lipman, Jeffrey
Roberts, Jason A
Published in Journal of Antimicrobial Chemotherapy. 2015, vol. 2015, no. 70, p. 3178-3183
Abstract Traditional antibiotic dosing was not designed for today's escalating antibiotic resistance, lack of novel antibiotics and growing complexity in patient populations. Dosing that ensures optimal antibiotic exposures should be considered essential to increase the likelihood of effective patient treatment. Given the variability in these exposures across different patients, a 'one-dose-fits-all' approach is increasingly problematic. Therapeutic drug monitoring (TDM) of the β-lactams, the most widely used antibiotic class, is underutilized in certain populations. Clinical experience with β-lactam TDM remains relatively scarce. Patients most likely to benefit from such an intervention include the critically ill, the obese, the elderly and those with cystic fibrosis. Most centres actively performing β-lactam TDM target a minimum 100% of the time during the dosing interval that the free (unbound) concentration of antibiotic exceeds the MIC of the pathogen (100% fT>MIC), which is higher than a traditional target supported by in vitro data. Ideally, isolated pathogens should undergo MIC testing along with TDM on a regular basis, allowing clinicians to address the triad of bug, drug and patient ('mug') in equal measure.
Identifiers
PMID: 26188037
Full text
Article (Published version) (226 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Research group Groupe Harbarth Stephan (Staphylocoques dorés résistants à la méthicilline) (866)
Citation
(ISO format)
HUTTNER, Angela et al. Therapeutic drug monitoring of the β-lactam antibiotics: what is the evidence and which patients should we be using it for?. In: Journal of Antimicrobial Chemotherapy, 2015, vol. 2015, n° 70, p. 3178-3183. https://archive-ouverte.unige.ch/unige:77978

132 hits

0 download

Update

Deposited on : 2015-12-01

Export document
Format :
Citation style :